The CooP peptide is a glioblastoma homing peptide identified, such as Lyp-1 by the in vivo selection of a phage display peptide library, whose interacting partner has been identified primarily to be the mammary-derived growth inhibitor (MDGI/FABP3) [15]. This evidence concerns the gene PTPN22 and glioblastoma.